On the Frontlines of AML/ALL

Acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) are among the most complex and aggressive hematologic malignancies. That’s why our On the Frontlines of AML/ALL series brings together leading hematologists and oncologists to examine emerging data, evolving treatment paradigms, and clinical strategies for optimizing outcomes across the continuum of AML and ALL care.